BamSEC and AlphaSense Join Forces
Learn More

EMI Holding, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 10-Q 4 pages Emmaus Life Sciences, Inc. Promissory Note
12/34/56
EX-10.24B
from 10-K 17 pages Second Amendment to Office Lease Agreement
12/34/56
EX-10.24A
from 10-K 12 pages First Amendment to Office Lease Agreement
12/34/56
EX-10.1
from DEFA14A 9 pages Securities Amendment Agreement
12/34/56
EX-10.1
from 8-K 9 pages Securities Amendment Agreement
12/34/56
EX-10.4
from 425 9 pages Form of Mynd Lock-Up Agreement
12/34/56
EX-10.4
from 8-K 9 pages Form of Mynd Lock-Up Agreement
12/34/56
EX-10.3
from 425 9 pages Form of Emmaus Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 9 pages Form of Emmaus Lock-Up Agreement
12/34/56
EX-10.2
from 8-K 16 pages Form of Mynd Voting Agreement
12/34/56
EX-10.2
from 425 16 pages Form of Mynd Voting Agreement
12/34/56
EX-10.1
from 425 16 pages Form of Emmaus Voting Agreement
12/34/56
EX-10.1
from 8-K 16 pages Form of Emmaus Voting Agreement
12/34/56
EX-10.6
from 8-K/A 3 pages Second Amendment to Securities Purchase Agreement
12/34/56
EX-10.5
from 8-K/A 4 pages W H E R E a S: A. This Agreement Amends and Restates in Its Entirety That Certain Transaction Fee Agreement, Dated as of August 24, 2018, Between the Company and the Broker
12/34/56
EX-10.4
from 8-K 3 pages 1.the Company Agrees to Compensate the Broker as Follows: (I) Four Percent (4%) of the Gross Proceeds Raised in the Offering, Payable at the Closing (As Defined in the Purchase Agreement), and (II) Fifty Thousand (50,000) 5-Year Warrants, Identical to the Investor Warrants (The “Broker Warrants”) to Broker or Its Designees at the Closing to Purchase Shares of Common Stock of Emmaus Life Sciences, Inc. With a Strike Price of $11.30 at the Closing of the Transaction. the Broker 1
12/34/56
EX-10.3
from 8-K 15 pages Subsidiary Guarantee
12/34/56
EX-10.2
from 8-K 38 pages Security Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Emmaus Life Sciences, Inc. Promissory Note
12/34/56